Predict your next investment

Corporation

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Level One Partners

Level One Partners does business in various industries.

Level One Partners Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Level One Partners News

Level One Partners Supports Watermill’s Proposal for Ziopharm Oncology

Nov 13, 2020

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Level One Partners, LLC, (“Level One Partners”) along with all of its related entities, will vote 100% of its approximately 10.68 million shares of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”) in support of the WaterMill Asset Management Corp. proposal for a reconstituted Board of Directors and significant changes to the governance of the Company. Level One Partners’ 10.68 million shares equal approximately 4.98% of the Company’s outstanding shares. Level One Partners stated: “We believe WaterMill’s proposed new board members possess the business acumen and experience necessary to help lead the Company in achieving its strategic goals. With new board member leadership, we believe the Company can begin to maximize shareholder value and unlock the potential of its extraordinary science.” Level One Partners, LLC, is a private investment firm located in Charlottesville, Virginia. Contacts

Level One Partners Investments

1 Investments

Level One Partners has made 1 investments. Their latest investment was in Candel Therapeutics as part of their Series C on April 4, 2019.

CBI Logo

Level One Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/1/2019

Series C

Candel Therapeutics

$22.5M

Yes

3

Date

4/1/2019

Round

Series C

Company

Candel Therapeutics

Amount

$22.5M

New?

Yes

Co-Investors

Sources

3

Level One Partners Portfolio Exits

1 Portfolio Exit

Level One Partners has 1 portfolio exit. Their latest portfolio exit was Candel Therapeutics on July 27, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/27/2021

IPO

$99M

9

Date

7/27/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Sources

9

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.